The FDA has granted breakthrough therapy designation to a gene therapy product aimed at hemophilia A.
Health plans are under fire for the hidden conflicts of interest in their clinical pathway panels.
Outcomes Research in Review
Reports From the Field
1. Bayliss M, Rendas-Baum R, White MK, et al. Health-related quality of life (HRQL) for individuals with self-reported chronic physical and/or...